Publications

1. Fang Z, Zhao X, Zhang Z, Wu J, Cheng J, Lei D, Li N, Ge R, He QY, Sun X. Unveiling a novel mechanism for competitive advantage of ciprofloxacin-resistant bacteria in the environment through bacterial membrane vesicles. J Hazard Mater. 2024 Mar 15;466:133453.

2. Fang Z, Lai F, Cao K, Zhang Z, Cao L, Liu S, Duan Y, Yin X, Ge R, He QY, Sun X. Potential Role of Lysine Acetylation in Antibiotic Resistance of Escherichia coli. mSystems. 2022 Dec 20;7(6):e0064922.  

3. Fang ZY, Zhang ZY, Zheng YD, Lei D, Zhuang J, Li N, He QY, Sun X. Repurposing cinacalcet suppresses multidrug-resistant Staphylococcus aureus by disruption of cell membrane and inhibits biofilm by targeting IcaR. J Antimicrob Chemother. 2024 Apr 2;79(4):903-917.

4. Zhuang J#, Liu S#, Du GF#, Fang Z#, Wu J, Li N, Zhong T, Xu J, He QY, Sun X. YjgM is a crotonyltransferase critical for polymyxin resistance of Escherichia coli. Cell Rep. 2024 May 28;43(5):114161.

5. Zheng YD, Zhong T, Wu H, Li N, Fang Z, Cao L, Yin XF, He QY, Ge R, Sun X. Crizotinib Shows Antibacterial Activity against Gram-Positive Bacteria by Reducing ATP Production and Targeting the CTP Synthase PyrG. Microbiol Spectr. 2022 Jun 29;10(3):e0088422.

Patent：

Sun X, Lei D, Fang Z, Application of Evacetrapib in the preparation of antibacterial drugs, authorized, authorization announcement number: CN114886900B